Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -DKK 22.3B, followed by BridgeBio Pharma (-DKK 14.2B) and Cytokinetics (-DKK 4.5B). Figures as of 18 Nov 2026, 16:35 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-DKK 22.3B
- Median
- DKK 6B
- Combined market value
- DKK 34.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -DKK 22.3B | DKK 3.48T | DKK 1,969.14 | 1.35% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -DKK 14.2B | DKK 103.3B | DKK 530.05 | 1.25% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -DKK 4.5B | DKK 48.7B | DKK 349.51 | 0.73% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -DKK 1.4B | DKK 34.3B | DKK 410.56 | 0.22% down | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -DKK 1.2B | DKK 120.9B | DKK 1,843.65 | 0.27% down | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -DKK 824.9M | DKK 36B | DKK 852.74 | 0.43% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -DKK 482.6M | DKK 51.2B | DKK 146.83 | 1.99% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | DKK 601.9M | DKK 47.6B | DKK 905.84 | 2.25% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | DKK 782.7M | DKK 33B | DKK 343.28 | 1.45% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 948M | DKK 55.3B | DKK 797.39 | 0.32% up | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | DKK 2.1B | DKK 40.7B | DKK 623.03 | 0.60% down | 31% up | ||
| 12 | ErascaERAS · Health Care | DKK 2.2B | DKK 31.6B | DKK 90.11 | 4.82% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | DKK 2.3B | DKK 26.7B | DKK 195.26 | 2.50% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 3.2B | DKK 41.5B | DKK 293.52 | 0.16% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | DKK 3.2B | DKK 44.7B | DKK 659.43 | 0.44% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | DKK 3.3B | DKK 31B | DKK 186.12 | 1.28% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | DKK 3.4B | DKK 33.1B | DKK 587.85 | 0.85% down | 113% up | ||
| 18 | ABIVAXABVX · Health Care | DKK 3.4B | DKK 50.2B | DKK 573.09 | 2.41% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | DKK 3.6B | DKK 30.7B | DKK 280.63 | 2.07% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 3.9B | DKK 51.4B | DKK 654.11 | 0.89% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.1B | DKK 64.6B | DKK 2,782.76 | 3.26% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | DKK 4.2B | DKK 55.7B | DKK 854.10 | 0.51% up | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | DKK 4.3B | DKK 33.6B | DKK 193.28 | 1.81% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | DKK 4.4B | DKK 50.9B | DKK 464.82 | 2.68% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | DKK 4.4B | DKK 67.2B | DKK 444.43 | 3.97% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | DKK 4.5B | DKK 58.1B | DKK 72.59 | 0.20% down | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | DKK 4.9B | DKK 61.8B | DKK 650.90 | 1.79% up | 286% up | ||
| 28 | InsmedINSM · Health Care | DKK 5B | DKK 179.7B | DKK 819.07 | 1.40% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | DKK 5.3B | DKK 44B | DKK 1,083.85 | 0.81% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | DKK 5.4B | DKK 139.1B | DKK 1,038.63 | 2.64% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | DKK 6B | DKK 58.2B | DKK 2,080.76 | 0.06% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | DKK 6.8B | DKK 21.5B | DKK 110.77 | 0.87% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | DKK 6.9B | DKK 41.1B | DKK 2,052.44 | 2.48% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | DKK 12.4B | DKK 53.5B | DKK 318.26 | 2.73% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | DKK 22.7B | DKK 232.8B | DKK 572.96 | 0.69% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 27.3B | DKK 85.2B | DKK 102.18 | 1.35% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 29.4B | DKK 106.8B | DKK 1,664.31 | 1.43% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | DKK 29.7B | DKK 315B | DKK 2,758.01 | 2.09% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | DKK 30.9B | DKK 190.3B | DKK 262.64 | 0.46% down | 90% up | ||
| 40 | GenmabGMAB · Health Care | DKK 39.9B | DKK 215.6B | DKK 349.62 | 1.29% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | DKK 39.9B | DKK 39.5B | DKK 58.01 | 1.39% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | DKK 41.5B | DKK 79.5B | DKK 410.62 | 2.96% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | DKK 44.6B | DKK 90.2B | DKK 180.50 | 2.44% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | DKK 48.4B | DKK 168.4B | DKK 3,954.44 | 0.68% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 53.9B | DKK 334.8B | DKK 286.97 | 1.22% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | DKK 66.2B | DKK 269.7B | DKK 469.04 | 0.19% up | 78% up | ||
| 47 | ViatrisVTRS · Health Care | DKK 100.3B | DKK 161.3B | DKK 140.66 | 0.90% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | DKK 125.9B | DKK 838.4B | DKK 410.15 | 1.92% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | DKK 127.2B | DKK 924.2B | DKK 3,645.28 | 0.11% up | 27% up | ||
| 50 | GSKGSK · Health Care | DKK 148.2B | DKK 667.3B | DKK 332.92 | 0.81% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | DKK 180.9B | DKK 8.45T | DKK 9,484.16 | 1.71% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | DKK 196.3B | DKK 1.19T | DKK 269.93 | 2.70% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | DKK 213.1B | DKK 676.5B | DKK 6,539.11 | 0.16% up | 36% up | ||
| 54 | NovartisNVS · Health Care | DKK 314.4B | DKK 2.01T | DKK 1,063.57 | 1.95% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | DKK 317.2B | DKK 465.6B | DKK 145.74 | 1.20% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | DKK 331.7B | DKK 1.89T | DKK 1,221.58 | 1.68% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | DKK 355.3B | DKK 1.23T | DKK 712.59 | 0.16% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | DKK 358.6B | DKK 2.35T | DKK 952.67 | 2.52% down | 51% up | ||
| 59 | SanofiSNY · Health Care | DKK 539.8B | DKK 775.2B | DKK 322.83 | 0.36% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | DKK 555.8B | DKK 4.53T | DKK 1,879.91 | 1.04% down | 38% up | ||
| 61 | PfizerPFE · Health Care | DKK 589.5B | DKK 1.09T | DKK 192.10 | 1.01% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8165 DKK).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-DKK 22.3B), BridgeBio Pharma (-DKK 14.2B) and Cytokinetics (-DKK 4.5B) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:35 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of DKK 34.7T as of 18 Nov 2026, 16:35 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.